Danaher Corporation (DHR)
$216.06+0.18%previous session's close (28 Aug 2026) — awaiting today's first price update
Spriggl Score: Moderate— sign in to explore; full breakdown with Premium
Last 30 trading days
Spriggl AI Verdict
“DBS transforms acquisitions; Masimo beat confirms execution, but higher leverage and rich valuation temper the outlook.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology se…
- Sector:
- Healthcare
- Industry:
- Diagnostics & Research
- Market Cap:
- $142.3B
Recent dividends
- 26 Jun 2026$0.40
- 27 Mar 2026$0.40
- 26 Dec 2025$0.32
Get the full Spriggl analysis — free
A free Spriggl account gets you the screener, a watchlist, AI verdicts and a free full report every day — across Danaher Corporation and 1,500+ UK and US stocks. The full score breakdown and AI analysis come with Premium.
Start free